4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0000921895-16-004737
10% owner sold 40,068 shares at an average $1.92 ($77,061)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center 10% owner | 2016-05-26 | Sale | −27,168 | $1.92 | $52,163 | 5,389,745 | D: show line 1 in the form |
| Memorial Sloan-Kettering Cancer Center 10% owner | 2016-05-26 | Sale | −12,700 | $1.93 | $24,511 | 5,377,045 | D: show line 2 in the form |
| Memorial Sloan-Kettering Cancer Center 10% owner | 2016-05-26 | Sale | −200 | $1.94 | $387 | 5,376,845 | D: show line 3 in the form |
| Open-market sales · 40,068 sh · avg $1.92 · $77,061 | |||||||
Loading xslF345X03/form410109001_05312016.xml…